The First Affiliated Hospital of Fujian Medical University
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China21 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT06139575 | |
| ASPIrin in Reducing Events in Dialysis ( ASPIRED ) | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Active, not recruiting | Phase 4 | 2026-09-14 | NCT04381143 | |
| Safety and Efficacy of Ventricular Irrigation for Ventriculitis | Infections, central nervous system disorder, central nervous system infectious disorder, nervous system disorder | Recruiting | Not applicable | 2026-09-10 | NCT06358209 | |
| A Study of ATG-022 Compared With Investigator's Choice of Treatment in Claudin 18.2-Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma | Advanced Gastric or Gastroesophageal Junction Adenocarcinoma | Not yet recruiting | Phase 3 | 2026-08-31 | NCT07795346 | |
| A Multicenter Exploratory Clinical Study of Iruplaltinib Combined With Pemetrexed as Neoadjuvant Therapy for Resectable ALK-Positive Non-Squamous Non-Small Cell Lung Cancer | ALK-positive Non Small Cell Lung Cancer | Not yet recruiting | Phase 2 | 2026-08-18 | NCT07771764 | |
| A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease | Active, not recruiting | Phase 3 | 2026-07-02 | NCT04849728 | |
| Evaluation of the Safety and Effectiveness of CHORDS® Cerebral Protection System During TAVR: DUET Trial | brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2026-06-15 | NCT07648693 | |
| Real-world Study of Aflibercept 8 mg in nAMD | Neovascular Age-Related Macular Degeneration (nAMD) | Recruiting | Not stated | 2026-06-11 | NCT07640997 | |
| Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, digestive system disorder, digestive system neoplasm, gastrointestinal stromal tumor, neoplasm | Recruiting | Phase 2 / Phase 3 | 2026-06-10 | NCT07379047 | |
| Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere | Unresectable Hepatocellular Carcinoma | Active, not recruiting | Phase 3 | 2026-06-09 | NCT06900543 | |
| Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER) | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, arthropathy, connective tissue neoplasm, disease of the tendon, giant cell tumor, muscle tissue disorder, musculoskeletal system disorder, neoplasm, synovitis, tenosynovial giant cell tumor, tenosynovial giant cell tumor, diffuse type | Active, not recruiting | Phase 3 | 2026-05-04 | NCT05804045 | |
| Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis | Moderate to Severe Ulcerative Colitis | Active, not recruiting | Phase 2 | 2026-04-03 | NCT05486104 | |
| Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial | ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; Acute Myeloid Leucemia; Conditioning; Myeldysplastic Syndrome (MDS); Myeloid Malignancies; Venentoclax | Recruiting | Phase 3 | 2026-03-17 | NCT07396480 | |
| Trial of CS060380 Tablets for Non-alcoholic Steatohepatitis (NASH) | metabolic dysfunction-associated steatohepatitis | Recruiting | Phase 2 | 2026-03-13 | NCT07198386 | |
| Rifampin-combined Antibiotic Therapy for Staphylococcal PJI | periprosthetic joint infection | Recruiting | Not applicable | 2025-12-31 | NCT07313215 | |
| Metabolic and Immunomic Differential Analysis of Primary Central Nervous System Diffuse Large B-Cell Lymphoma | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Not stated | 2025-11-18 | NCT07188077 | |
| Selinexor in Combination With MTX+Ritu to Treat R/R CNSL | primary central nervous system lymphoma | Recruiting | Phase 1 / Phase 2 | 2025-09-16 | NCT05698147 | |
| A Phase III Clinical Study of H077 Sustained-Release Tablets Compared With Silodosin Capsules in the Treatment of Benign Prostatic Hyperplasia | Genital Diseases, Lower Urinary Tract Symptoms, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urological Manifestations, benign prostatic hyperplasia, male reproductive system disorder, prostate disorder | Not yet recruiting | Phase 3 | 2025-08-28 | NCT07146386 | |
| The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM). | Type1 Diabetes Mellitus | Not yet recruiting | Not stated | 2024-09-23 | NCT06606509 | |
| Registry of Multicenter Brain-Heart Comorbidity in China | Aneurysm, Arrhythmias, Cardiac, Arterial Occlusive Diseases, Bites and Stings, Cardiovascular Abnormalities, Central Nervous System Vascular Malformations, Cerebral Aneurysm, Chemically-Induced Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemorrhage, Infarction, Intracranial Hemorrhages, Moyamoya disease, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, aortic disorder, arteriovenous hemangioma/malformation, arteriovenous malformations of the brain, atrial fibrillation, brain aneurysm, brain disorder, brain infarction, brain ischemia, cardiac arrest, cardiovascular disorder, carotid artery disorder, central nervous system disorder, central nervous system malformation, cerebral arterial disease, cerebral infarction, cerebrovascular disorder, heart disorder, heart failure, injury, intracerebral hemorrhage, intracranial arterial disease, ischemic disease, myocardial ischemia, nervous system disorder, poisoning, stroke disorder, subarachnoid hemorrhage, vascular disorder, vascular malformation | Recruiting | Not stated | 2023-09-21 | NCT05961748 | |
| Prospective Cohort Study on Antibiotic Course and Efficacy After Two-stage Revision in PJI. | periprosthetic joint infection | Recruiting | Not stated | 2022-03-17 | NCT05284318 |